Correlation Between Tarsus Pharmaceuticals and Parker Hannifin
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Parker Hannifin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Parker Hannifin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Parker Hannifin, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Parker Hannifin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Parker Hannifin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Parker Hannifin.
Diversification Opportunities for Tarsus Pharmaceuticals and Parker Hannifin
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Tarsus and Parker is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Parker Hannifin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Parker Hannifin and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Parker Hannifin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Parker Hannifin has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Parker Hannifin go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Parker Hannifin
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.14 times more return on investment than Parker Hannifin. However, Tarsus Pharmaceuticals is 1.14 times more volatile than Parker Hannifin. It trades about 0.26 of its potential returns per unit of risk. Parker Hannifin is currently generating about 0.23 per unit of risk. If you would invest 4,621 in Tarsus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 624.00 from holding Tarsus Pharmaceuticals or generate 13.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Parker Hannifin
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Parker Hannifin |
Tarsus Pharmaceuticals and Parker Hannifin Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Parker Hannifin
The main advantage of trading using opposite Tarsus Pharmaceuticals and Parker Hannifin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Parker Hannifin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Parker Hannifin will offset losses from the drop in Parker Hannifin's long position.| Tarsus Pharmaceuticals vs. DiaMedica Therapeutics | Tarsus Pharmaceuticals vs. Lyra Therapeutics | Tarsus Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| Parker Hannifin vs. Illinois Tool Works | Parker Hannifin vs. Pentair PLC | Parker Hannifin vs. Emerson Electric | Parker Hannifin vs. Smith AO |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |